ADMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Law firm Faruqi & Faruqi encourages investors who suffered losses in ADMA Biologics to contact its Securities Litigation Partner James (Josh) Wilson to discuss potential options. The note provides no details on claims, alleged damages, or any company-specific financial impact, so near-term market implications appear limited.

Analysis

Law firm Faruqi & Faruqi encourages investors who suffered losses in ADMA Biologics to contact its Securities Litigation Partner James (Josh) Wilson to discuss potential options. The note provides no details on claims, alleged damages, or any company-specific financial impact, so near-term market implications appear limited.